1. Home
  2. MNKD vs GNL Comparison

MNKD vs GNL Comparison

Compare MNKD & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • GNL
  • Stock Information
  • Founded
  • MNKD 1991
  • GNL 2011
  • Country
  • MNKD United States
  • GNL United States
  • Employees
  • MNKD N/A
  • GNL N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • GNL Real Estate Investment Trusts
  • Sector
  • MNKD Health Care
  • GNL Real Estate
  • Exchange
  • MNKD Nasdaq
  • GNL Nasdaq
  • Market Cap
  • MNKD 1.5B
  • GNL 1.6B
  • IPO Year
  • MNKD 2004
  • GNL N/A
  • Fundamental
  • Price
  • MNKD $5.76
  • GNL $7.24
  • Analyst Decision
  • MNKD Buy
  • GNL Buy
  • Analyst Count
  • MNKD 6
  • GNL 5
  • Target Price
  • MNKD $8.92
  • GNL $9.50
  • AVG Volume (30 Days)
  • MNKD 1.7M
  • GNL 1.1M
  • Earning Date
  • MNKD 02-26-2025
  • GNL 02-27-2025
  • Dividend Yield
  • MNKD N/A
  • GNL 15.23%
  • EPS Growth
  • MNKD N/A
  • GNL N/A
  • EPS
  • MNKD 0.08
  • GNL N/A
  • Revenue
  • MNKD $267,200,000.00
  • GNL $812,621,000.00
  • Revenue This Year
  • MNKD $44.15
  • GNL N/A
  • Revenue Next Year
  • MNKD $19.65
  • GNL N/A
  • P/E Ratio
  • MNKD $72.34
  • GNL N/A
  • Revenue Growth
  • MNKD 51.35
  • GNL 102.00
  • 52 Week Low
  • MNKD $3.47
  • GNL $6.52
  • 52 Week High
  • MNKD $7.63
  • GNL $9.11
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 48.03
  • GNL 52.39
  • Support Level
  • MNKD $5.32
  • GNL $7.06
  • Resistance Level
  • MNKD $5.65
  • GNL $7.31
  • Average True Range (ATR)
  • MNKD 0.18
  • GNL 0.14
  • MACD
  • MNKD 0.03
  • GNL 0.01
  • Stochastic Oscillator
  • MNKD 81.48
  • GNL 71.05

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About GNL Global Net Lease Inc.

Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail ; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.

Share on Social Networks: